Predictive Value Positive of MTM Eligibility Criteria under MMA and ACA in Identifying Individuals with Medication Utilization Issues.

Yanru QiaoChristina A SpiveyJunling WangYa-Chen Tina ShihJim Y WanJulie KuhleSamuel Dagogo-JackWilliam C CushmanMarie Chisholm-Burns

Published in: Journal of pharmaceutical health services research : an official journal of the Royal Pharmaceutical Society of Great Britain (2018)

MMA has higher PVP than ACA in identifying patients with MUI. This study may inform the government on future MTM policy.

Keyphrases

healthcare
public health
affordable care act
mental health
adverse drug
health insurance